Dividend compounder review

PEN

Penumbra Inc · NYSE · US

Healthcare · Medical Devices

Chart Factor Intelligence Back to Screener
Score46.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 22.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 4.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$177.7M
Free Cash Flow$174.9M
FCF Covers DividendUnknown
Debt / Equity0.15
P/E73.6
Revenue Growth 5Y20.2%
Net Margin11.8%
ROE12.7%
Price vs Trend-2.6%
3Y Return-4.6%
5Y Return12.5%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

PEN dividend review warning Warning · Warning

No usable dividend history found.